The company announced last week it had delivered a record volume of injectable medication to the United States, worth a total $3.4 million.
Antibiotice plans to open an office in Vietnam this year to enhance business in Southeast Asia and plans to raise medication sales to Vietnam by 30% in 2016 and to triple volumes by 2020.
The company expects revenues of RON350 million this year and a gross profit of RON34 million, up 6% compared with 2015.
Last year, Antibiotice had a turnover of RON332 million, up 3% on the year, and a net profit of RON27 million, down 13% on the year.